Prolyl 4-hydroxylase (EC 1.14.11.2) is an essential enzyme in the post-translational modification of collagen. Inhibitors of this enzyme are of potential interest for the treatment of diseases involving excessive deposition of collagen. 2,7,8-Trihydroxyanthraquinone (THA) is an effective inhibitor of prolyl 4-hydroxylase by virtue of its ability to compete with the co-substrate 2-oxoglutarate (K, = 40.3 #tM). Using a simple and reproducible assay for collagen hydroxylation, we show that THA inhibits the hydroxylation of collagen in embryonic-chick tendon cells in short-term culture, with an IC50 value (concn. giving 50 % inhibition) of 32 /tM. In comparison, the ethyl ester of 3,4-dihydroxybenzoic acid has an IC50 value of 0.1 mm against collagen hydroxylation by chick tendon cells, whereas its K1 versus isolated prolyl 4-hydroxylase is 49,tM.
INTRODUCTION
The hydroxylation ofcertain prolyl residues ofcollagen pro-a-chains is essential for the formation of the characteristic triple helix of the mature collagen molecule. Since secretion of collagen into the extracellular matrix only occurs when the molecule is in the triple-helical form (Uitto & Prockop, 1974) , the principal enzyme involved in collagen hydroxylation, prolyl 4-hydroxylase (EC 1.14.11.2), is seen as a potential target for drugs that could be used to treat a range of serious diseases characterized by excessive deposition of collagen. These include fibrosis of the lungs and liver, scleroderma and the proliferative pannus of rheumatoid arthritis. Although several inhibitors of prolyl 4-hydroxylase have been described, their usefulness against intact cells has been limited by several factors, including lack of specificity, e.g. the antitumour antibiotic P-1894B (Ishimaru et al., 1982) and 2,2'-bipyridyl (Tschank et al., 1987a) , and difficulty in crossing the cell membrane, as with several pyridinedicarboxylic acids (Tschank et al., 1987a) and possibly the ethyl ester of 3,4-dihydroxybenzoic acid (Sasaki et al., 1987) . A previous report from our laboratory described the inhibition of chick prolyl 4-hydroxylase by a series of hydroxyanthraquinones having at least two hydroxy groups ortho to each other. In the present paper we show that one of these compounds, 2,7,8-trihydroxyanthraquinone (THA), is a potent non-toxic inhibitor ofcollagen hydroxylation in embryonic-chick tendon cells in vitro. 
MATERIALS AND METHODS

Isolation of embryonic-chick tendon cells
Cells were isolated from the leg tendons of 17-day chick embryos by a modification of a previous procedure (Dehm & Prockop, 1971 tubes together with two washes (1 ml) of the incubation bottles with ice-cold EDTA (1 mM). Ice-cold trichloroacetic acid was added to a final concentration of 10 % (w/v), and the tubes were left on ice for 1 h. The precipitated proteins were sedimented by centrifugation and resuspended twice in ice-cold trichloroacetic acid (5 %).
Incorporation of radiolabel into collagen was determined by a modification of the collagenase procedure of Peterkofsky & Diegelmann (1971) . Each protein precipitate was dissolved in 0.2 M-NaOH (1 ml). . The determination of the extent of hydroxylation of prolyl residues at the 4-position in collagenase-solubilized material was based on the elimination of 3H from incorporated prolyl residues (Chojkier et al., 1980) . Since hydroxylation only occurs at the 4-trans position, it was important to take account of the proportion of 3H in this position in the added labelled proline (63 %). Owing to hydroxylation, the ratio of 3H to 14C in collagen is normally smaller than that in noncollagenous proteins and in collagen when hydroxylation is suppressed by inhibitors of hydroxylation such as 2,2'-bipyridyl. In material evaluated in the present study is a mixture of collagen secreted into the medium and intracellular collagen. A significant proportion of the latter is likely to be incompletely hydroxylated. The reproducibility of the percentage hydroxylation in a long series of experiments encouraged the view that the procedure for measuring hydroxylation described in the present paper could be used to compare the effects of inhibitors of prolyl 4-hydroxylase on the intracellular hydroxylation of collagen. (Cunliffe & Frankin, 1986 Dehm & Prockop (1971) . THA may also have had a smaller effect on cell viability over 3 h (95 % viability after 3 h incubation) than 2,2'-bipyridyl (9000 viability). In all further investigations of inhibitors of collagen hydroxylation in tendon cells, therefore, we substituted THA for 2,2'-bipyridyl as an agent to suppress hydroxylation. The ratio of 3H/14C in collagenasesoluble peptides from cells incubated with 78 /sM-THA (Table 1 ) then replaced that obtained with 2,2'-bipyridyl in the expression to calculate percentage hydroxylation. Inhibition of collagen hydroxylation in tendon cells by EDHB EDHB has been reported to be considerably more effective as an inhibitor of collagen hydroxylation in cultures of human keloid fibroblasts than its less hydrophilic parent compound 3,4-dihydroxybenzoic acid (Sasaki et al. 1987) . Although a complete dose-response curve was not reported, EDHB inhibited hydroxylation by 80 % at 0.4 mM and 390 at 0.2 mM. In a series of 20 experiments with different batches of cells, we observed a mean inhibition of collagen hydroxylation by EDHB in chick tendon cells of 43.1 00+2.9 (S.E.M.) at 0.109mM (20 ,ug/ml). A full dose-response study gave an IC50 of 0.1 mm against collagen hydroxylation in chick tendon cells (Fig. 2) the possibility of partial hydrolysis of the ester to the free acid during incubation with the enzyme cannot be ruled out.
DISCUSSION
Conventional procedures for measuring the hydroxylation of prolyl residues in collagen pro-a chains usually rely on monitoring the incorporation of radiolabelled proline into hydroxyproline. This requires the separation of hydroxyproline from proline in protein hydrolysates by chromatography. Chojkier et al. (1980) showed that proline hydroxylation in guinea-pig calvaria in vitro could be determined by measuring the simultaneous incorporation of ['4C]proline and [3H]proline into the collagenase-soluble fraction. The ratio of radiolabels in collagen obtained in the presence of 2,2'-bipyridyl was used as an indicator of zero hydroxylation. We have found that an adaptation of this method for suspensions of embryonic tendon cells is a convenient and reliable way of determining the extent of hydroxylation of prolyl residues in the 4-position in these cells in vitro.
Using this technique, we found that THA is among the most potent inhibitors of intracellular collagen hydroxylation so far reported, with an IC50 of 32 zm. The KI for this compound against purified chick prolyl 4-hydroxylase is 40.3 /tM . It should be borne in mind that the Ki for THA was determined in the presence of 50 ,uM-Fe2 , the concentration required for optimal enzyme activity. The inhibitory potency of THA against prolyl 4-hydroxylase increased in the absence of Fe2", presumably a reflection of the chelating affinity of THA for Fe2+ in solution . Since the prevailing concentration of free Fe2" at the intracellular site of prolyl hydroxylase is likely to be much lower than 50 4uM, the 'real' Ki of THA will be considerably less than 40.3 /iM. Furthermore, because no value is available for the concentration of 2-oxoglutarate (the co-substrate antagonized by THA) at the intracellular site of prolyl hydroxylase, we cannot directly relate the IC50 value against collagen hydroxylation to the observed Ki value against the isolated enzyme. It is possible that THA may diffuse relatively freely across the cellular permeability barriers to the intracellular site of the enzyme, although direct evidence for this is lacking. Unlike 2,2'-bipyridyl, THA had only a minor effect on the incorporation of ['4C] proline into collagen at a concentration that completely suppressed the 4-hydroxylation of prolyl residues.
3,4-Dihydroxybenzoic acid has a Ki against chick prolyl hydroxylase of approx. 46 /tM (Majamaa et al., 1986 ; the present work), but the compound had little or no effect on collagen hydroxylation in human keloid fibroblasts in vitro at concentrations between 0.2 and 0.4 mm (Sasaki et al., 1987) or in chick tendon cells (T. J. Franklin & M. Hitchen, unpublished work). Sasaki et al. (1987) therefore synthesized the ethyl ester of 3,4-dihydroxybenzoic acid (EDHB) in an attempt to produce a hydrophobic derivative which would diffuse across the permeability barriers to the intracellular site of the enzyme. However, even the ester required a concentration of 0.2 mm to inhibit hydroxyproline synthesis by approx. 40 % (Sasaki et al., 1987) . The results in the present paper show that EDHB has similarly modest activity against collagen hydroxylation in embryonic-chick tendon cells, with an IC50 value of 0.1 mm. The discrepancy between the inhibitory potency of EDHB against prolyl hydroxylase and against intracellular hydroxylation in both human and chick cells may have been due to slow penetration into the cells, despite greater hydrophobicity compared with the free acid. However, work by Tschank et al. (1987b) indicates that the mechanism of inhibition of prolyl hydroxylase by 3,4-dihydroxybenzoic acid in preparations of endoplasmic reticulum may be different from that which inhibits the purified enzyme. They speculate that intracellular conversion of the catechol into a highly reactive molecule in the presence of metal ions and oxygen might lead to the inactivation of postulated specific uptake processes for 2-oxoglutarate and ascorbate into the vesicles of the endoplasmic reticulum. Unlike 3,4-dihydroxybenzoic acid, THA is not a competitive inhibitor of ascorbate action, but exhibits positively co-operative competition with 2-oxoglutarate Metal ions known to inhibit prolyl hydroxylase have also been used to inhibit collagen hydroxylation in cultured cells and tissue explants. Antinnen et al. (1980) found that 1O ,tM-Zn2+ inhibited prolyl hydroxylation in chick tendon cells by approx. 35 %. Co2' achieved a similar effect at 0.1 mm. Rapaka et al. (1976) showed that 0.6 mM-Pd2+ inhibited hydroxyproline synthesis in embryonic-chick cartilage explants by 90 % or more. However, in contrast with THA, concentrations of Zn2+ and Pd21 which depressed collagen hydroxylation also inhibited collagen synthesis.
In conclusion, therefore, we have demonstrated that THA inhibits the prolyl 4-hydroxylation of collagen in tendon cells in vitro at concentrations which approximate to those that inhibit isolated prolyl 4-hydroxylase and which cause minimal toxicity to the cells. The compound would be expected to prevent the secretion of collagen into the extracellular matrix, since this process depends on the hydroxylation of specific proline residues in protocollagen. Recent results have confirmed that, when hydroxylation is inhibited by THA, embryonic-chick tendon cells fail to release collagen into the medium (T. J. Franklin & S. M. Hitchen, unpublished work). Although the compound lacks the potency required of a drug, our findings should encourage the search for more potent inhibitors which could be used to treat the serious diseases characterized by the hypersecretion of collagen into the extracellular matrix.
